Record

Pfizer as of November 10, 2026 · AsOf

organization

Pfizer

Pfizer is an American multinational pharmaceutical and biotechnology corporation, headquartered in New York. It reported revenue of $62.58B for the period ended December 31, 2025.

Chair: Albert Bourla sec.gov
Headquarters: New York sec.gov
Revenue: $62.58B to 2025-12-31 sec.gov
Ticker: PFE · NYSE sec.gov

Read the record as of a date

Compare the record on two dates →

State as of 2026-11-10

4 assertedThe record stands behind this value for the day asked: two independent sources agree, or a primary source states it (alone, at confidence 0.7 or more). Everything else stays on the record, labelled.More in About → facts

Pfizer: state as of 2026-11-10, one row per fact with its value, date, confidence and sources
fact	value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →

Latest

0 dated events · full timeline →

No dated events on the record yet.

Releases, deals, appointments and policy changes land here once a checked source dates them.

Every claim on the timeline, including undated ones →

Financials

latest period on record · change vs prior year

Revenue

$62.58B

2025-12-31-1.6%

every revenue figure →

Net income

$7.77B

2025-12-31-3.2%

every net income figure →

Total assets

$204.54B

2026-09-27-2.0%

Cash

$1.82B

2026-09-27+35.8%

As reported in the linked filings, which may be restated. Not investment advice.

State changes since 2026-05-14

18 changes · supersededA later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.More in About →

2026-10-28 · shares outstandingshares outstanding

sec.gov: 1 source for shares outstanding, claim clm_7F37B9735E29

2026-07-29 · shares outstandingshares outstanding

sec.gov: 1 source for shares outstanding, claim clm_E03E2668E863 replaced by →

2026-09-27 · cash and equivalentscash and equivalents

About this record

Identifiers7 keys · schema.org snippet

AsOf ID: ent_pfizer
Wikidata: Q206921
SEC CIK: 0000078003
fiscal year end: 12-31
SIC industry: Pharmaceutical Preparations (2834)
incorporated in: DE
ticker: PFE

Cite this record in schema.org

"sameAs": ["https://www.wikidata.org/wiki/Q206921", "https://asof.is/record/pfizer"],
"identifier": { "@type": "PropertyValue", "propertyID": "asof", "value": "ent_pfizer" }

Paste into the entity's JSON-LD. Why and how.

Sources on this entity1 site · 440 citations

sec.govprimary · 440

Get this recordmarkdown · JSON · MCP

439 claims on record, 17 currently valid, 422 superseded. Last change 2026-10-28.

quarterly net income	3,242,000,000 United States dollar 2026-09-27sec.gov: 1 source for quarterly net income, claim clm_7B5F356BDB2E	2026-09-27	0.95	sec.gov: 1 source for quarterly net income, claim clm_7B5F356BDB2E
quarterly revenue	16,583,000,000 United States dollar 2026-09-27sec.gov: 1 source for quarterly revenue, claim clm_F01F5C40574B	2026-09-27	0.95	sec.gov: 1 source for quarterly revenue, claim clm_F01F5C40574B
shares outstanding	5,699,853,733 shares 2026-10-28sec.gov: 1 source for shares outstanding, claim clm_7F37B9735E29	2026-10-28	0.95	sec.gov: 1 source for shares outstanding, claim clm_7F37B9735E29
total equity	2026-09-27sec.gov: 1 source for total equity, claim clm_84ED4CDADE9C	2026-09-27	0.95	sec.gov: 1 source for total equity, claim clm_84ED4CDADE9C